# Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

> **NCT01851954** · PHASE2 · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 6 (actual)

## Conditions studied

- Very Low Birth Weight Infant
- Ureaplasma/Mycoplasma Positive

## Interventions

- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT01851954
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** declined enrollment
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851954, "Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01851954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*